Sign in
Stories
Advancements in Cancer Profiling & Disease Diagnostics
Share
Advancements in Prostate Cancer Diagnost...
Cancer Diagnostics Market Analysis
Cancer Diagnostics Market Analysis Insig...
Cancer Diagnostics Market Analysis Overv...
Overview
API
Immunis.AI introduces a novel blood-based immune profiling platform for prostate cancer risk stratification, potentially revolutionizing surveillance methods. Meanwhile, the global monkeypox diagnostics market sees increased demand due to the spread of the disease beyond Africa.
Ask a question
How might the adoption of Immunis.AI's blood-based platform impact the standard procedures for prostate cancer surveillance?
In what ways could advancements in immune profiling technology influence the development of treatments for other types of cancer?
What challenges and opportunities arise from the growing demand for monkeypox diagnostics outside of Africa?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage
01net
bnnbr